Angiotensin II

Biomarker1 paper

  • Human trial1

Funding

National Institute on AgingUS$1.5mNational Heart, Lung, and Blood InstituteUS$418.2k3 grants since 2017

Latest

Nov 2025: 2Dec 2025: 3Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 7Oct 2026: 013
Drugs & AgingHumans

RAS inhibitors linked to lower dementia risk than CCBs

Incidence of all-cause dementia was 1.26 per 1000 person-years with RAS inhibitors versus 1.89 with calcium channel blockers (HR 0.68).Incidence of all-cause dementia was 1.26 per 1000 person-years with RAS inhibitors versus 1.89 with calcium channel blockers (HR 0.68).